Gaudium IVF and Women Health Ltd.

•

gaudiumivfcentre.comBSE: 544709NSE: GAUDIUMIVF

Market Cap₹ 846 Cr.

Current Price

High / Low₹ 163 / 69

Stock P/E34.6

Book Value₹ 21

Price to Book5.50

Dividend Yield0.00 %

ROCE50.1 %

ROE52.2 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 59.4%
Company has a healthy return on capital (ROCE) of 58.5%
Latest quarter profit grew 175.3% YoY, showing strong momentum
Operating margins have improved to 40.8% from 37.0%
Company comfortably covers its interest (16.5x coverage)
Company maintains a comfortable, low leverage position

CONS

Receivables are growing faster than sales - a possible quality concern
Debtor days have increased from 55 to 120
Inventory has been piling up - inventory days up from 14 to 24
Though reporting repeated profits, the company pays out little dividend (0.0%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	APOLLOHOSP	8670.00	59.66	124661.30	0.23	610.40	38.41	7043.50	20.56	21.73	15.70
2.	MANIPALHOS	729.75	107.57	95989.65	0.00	2434.30	—	30906.30	—	13.93	23.83
3.	MAXHEALTH	985.00	65.80	95867.73	0.20	322.96	4.87	2366.17	16.70	14.97	25.29
4.	FORTIS	910.00	65.56	68701.19	0.11	272.80	2.26	2545.03	17.46	14.07	21.28
5.	ASTERDM	785.80	214.94	68496.02	0.00	29.28	-68.70	1310.68	21.60	11.46	19.53
6.	MEDANTA	1468.85	71.01	39493.23	0.03	157.25	-1.09	1304.05	26.50	19.38	21.99
7.	NH	1859.10	46.55	37992.72	0.24	207.27	5.37	2683.63	78.05	16.20	17.43
8.	KIMS	764.15	157.10	32094.80	0.00	37.40	-56.00	1179.50	35.33	11.51	19.03
9.	LALPATHLAB	1874.90	58.07	31469.98	1.09	1705.00	1172.39	7977.00	1090.95	29.56	31.03
10.	AGARWALEYE	514.15	109.86	16299.90	0.00	55.02	44.56	614.02	25.97	16.14	27.75
11.	VIJAYA	1496.35	82.20	15412.06	0.13	53.10	37.61	230.98	22.83	30.28	42.66
12.	GAUDIUMIVF	116.25	34.59	846.15	0.00	17.76	175.31	193.77	619.69	50.15	12.51

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026	Jun 2026
	14	27	18	25	30	19
	9	18	14	18	18	18
Operating Profit	6	9	4	7	12	1
OPM %	39.29%	32.39%	22.80%	26.72%	40.10%	6.85%
	0	0	0	0	0	1
Interest	0	0	0	1	1	0
Depreciation	1	0	1	0	1	1
Profit before Tax	5	8	4	5	10	2
Tax %	27.72%	20.83%	24.01%	26.81%	19.87%	27.51%
Net Profit	0	0	3	4	8	2
	0.55	1.05	0.50	0.59	1.34	0.25

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	37	44	48	71	92
	23	24	28	42	68
Operating Profit	14	20	19	29	24
OPM %	37.04%	45.69%	40.59%	40.83%	26.19%
	0	0	0	0	1
Interest	1	0	1	2	3
Depreciation	1	1	2	2	2
Profit before Tax	12	18	17	25	22
Tax %	26.43%	26.14%	37.97%	24.76%	23.06%
Net Profit	9	14	10	19	17
EPS	1.44	136.59	104.19	3.12	—
Dividend Payout %	0.00%	46.95%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 25%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 29%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 59%
Last Year:: 52%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	1	1	1	31
	8	22	26	16
	6	11	17	20
Trade Payables	1	1	1	14
	1	1	6	8
Total Liabilities	18	37	51	89
	4	18	19	18
	0	0	0	5
	0	1	2	7
	0	0	14	33
Cash & Bank	2	15	12	7
	12	2	5	18
Total Assets	18	37	51	89

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	2	29	3	9
Cash from Investing	-1	-16	-5	-15
Cash from Financing	3	5	-1	2
	0	13	-3	-5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	89.16	136.59	104.19	3.12
Book Value (₹)	93.86	229.55	272.53	7.54
Dividend per Share (₹)	0.00	64.13	0.00	0.00
Cash EPS (₹)	1.60	2.44	2.03	3.45
PROFITABILITY
Operating Margin %	37.05%	45.74%	40.59%	40.83%
Net Margin %	24.17%	30.57%	21.54%	27.05%
ROE %	94.99%	84.47%	41.50%	52.20%
ROCE %	82.39%	78.74%	46.65%	50.15%
	50.27%	49.92%	23.55%	27.42%
EFFICIENCY
Debtor Days	65	31	55	120
Inventory Days	3	8	14	24
Payable Days	114	87	72	178
	-46	-49	-3	-34
FINANCIAL HEALTH
Debt to Equity (x)	0.64x	0.43x	0.58x	0.41x
Interest Coverage (x)	22.44x	38.53x	19.23x	16.46x
	2.29x	1.92x	1.50x	1.42x
GROWTH
Revenue Growth %	0.00%	21.13%	8.26%	47.68%
Operating Profit Growth %	0.00%	49.55%	-2.63%	47.76%
Net Profit Growth %	0.00%	53.21%	-23.72%	85.40%
	0.00%	0.00%	-23.72%	-97.01%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.25x	1.46x

Shareholding Pattern

Numbers in percentages

	Feb 2026	Mar 2026	Jun 2026
	71.29	71.29	71.29
	9.24	6.70	3.01
	5.01	2.63	2.22
Government	0.00	0.00	0.00
	14.26	19.39	23.47

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

Copy of Newspaper Publication

2026-09-04 - Gaudium IVF and Women Health Limited has informed the Exchange about Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information.

2026-09-03

Updates

2026-09-03 - Gaudium IVF and Women Health Limited has informed the Exchange regarding 'Letter Shareholders providing the weblink and navigation path for accessing the Annual Report for the Financial Year 2025-26 pursuant to Regulation 36(1)(b) of Listing Regulations.'

2026-09-03

Shareholders meeting

2026-09-03 - Gaudium IVF and Women Health Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Gaudium IVF and Women Health Limited has informed the Exchange about Copy of Newspaper Publication regarding Pre-AGM Notice of 11th Annual General Meeting to be on Monday, September 28, 2026, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).

2026-08-19

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-19 - Gaudium IVF and Women Health Limited has informed the Exchange about Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

2026-08-14

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026.

2026-08-14

Copy of Newspaper Publication

2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about the Newspaper publication of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

2026-08-14

Investor Presentation

2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

2026-08-13

Investor Presentation

2026-08-13 - Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

News

Recent coverage and analyst commentary for GAUDIUMIVF

Loading news…

🤖

AI Stock Analyst

Gaudium IVF and Women Health Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

APOLLOHOSP

8670.00

59.66

124661.30

0.23

610.40

38.41

7043.50

20.56

21.73

15.70

MANIPALHOS

729.75

107.57

95989.65

0.00

2434.30

—

30906.30

—

13.93

23.83

MAXHEALTH

985.00

65.80

95867.73

0.20

322.96

4.87

2366.17

16.70

14.97

25.29

FORTIS

910.00

65.56

68701.19

0.11

272.80

2.26

2545.03

17.46

14.07

21.28

ASTERDM

785.80

214.94

68496.02

0.00

29.28

-68.70

1310.68

21.60

11.46

19.53

MEDANTA

1468.85

71.01

39493.23

0.03

157.25

-1.09

1304.05

26.50

19.38

21.99

1859.10

46.55

37992.72

0.24

207.27

5.37

2683.63

78.05

16.20

17.43

KIMS

764.15

157.10

32094.80

0.00

37.40

-56.00

1179.50

35.33

11.51

19.03

LALPATHLAB

1874.90

58.07

31469.98

1.09

1705.00

1172.39

7977.00

1090.95

29.56

31.03

AGARWALEYE

514.15

109.86

16299.90

0.00

55.02

44.56

614.02

25.97

16.14

27.75

VIJAYA

1496.35

82.20

15412.06

0.13

53.10

37.61

230.98

22.83

30.28

42.66

GAUDIUMIVF

116.25

34.59

846.15

0.00

17.76

175.31

193.77

619.69

50.15

12.51

Dec 2024

Mar 2025

Jun 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

39.29%

32.39%

22.80%

26.72%

40.10%

6.85%

Interest

Depreciation

Profit before Tax

Tax %

27.72%

20.83%

24.01%

26.81%

19.87%

27.51%

Net Profit

0.55

1.05

0.50

0.59

1.34

0.25

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

Operating Profit

OPM %

37.04%

45.69%

40.59%

40.83%

26.19%

Interest

Depreciation

Profit before Tax

Tax %

26.43%

26.14%

37.97%

24.76%

23.06%

Net Profit

EPS

1.44

136.59

104.19

3.12

—

Dividend Payout %

0.00%

46.95%

0.00%

—

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

Trade Payables

Total Liabilities

Cash & Bank

Total Assets

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Cash from Investing

-1

-16

-5

-15

Cash from Financing

-1

-3

-5

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

89.16

136.59

104.19

3.12

Book Value (₹)

93.86

229.55

272.53

7.54

Dividend per Share (₹)

0.00

64.13

0.00

Cash EPS (₹)

1.60

2.44

2.03

3.45

PROFITABILITY

Operating Margin %

37.05%

45.74%

40.59%

40.83%

Net Margin %

24.17%

30.57%

21.54%

27.05%

ROE %

94.99%

84.47%

41.50%

52.20%

ROCE %

82.39%

78.74%

46.65%

50.15%

50.27%

49.92%

23.55%

27.42%

EFFICIENCY

Debtor Days

120

Inventory Days

Payable Days

114

178

-46

-49

-3

-34

FINANCIAL HEALTH

Debt to Equity (x)

0.64x

0.43x

0.58x

0.41x

Interest Coverage (x)

22.44x

38.53x

19.23x

16.46x

2.29x

1.92x

1.50x

1.42x

GROWTH

Revenue Growth %

0.00%

21.13%

8.26%

47.68%

Operating Profit Growth %

0.00%

49.55%

-2.63%

47.76%

Net Profit Growth %

0.00%

53.21%

-23.72%

85.40%

0.00%

-23.72%

-97.01%

VALUATION

P/E (x)

0.00x

P/B (x)

0.00x

Dividend Yield %

0.00%

0.00x

0.25x

1.46x

Feb 2026

Mar 2026

Jun 2026

71.29

9.24

6.70

3.01

5.01

2.63

2.22

Government

0.00

14.26

19.39

23.47

Gaudium IVF and Women Health Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Gaudium IVF and Women Health Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI